Chemoinformaics analysis of 3,4 –dihydroxybenzoic acid
| Molecular Weight | 280.364 | nRot | 9 |
| Heavy Atom Molecular Weight | 256.172 | nRig | 7 |
| Exact Molecular Weight | 280.167 | nRing | 1 |
| Solubility: LogS | -3.774 | nHRing | 0 |
| Solubility: LogP | 4.867 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 44 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 45.931 |
| nHD | 2 | BPOL | 26.681 |
| QED | 0.407 |
| Synth | 1.878 |
| Natural Product Likeliness | 0.389 |
| NR-PPAR-gamma | 0.838 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.782 |
| MDCK | 0.0000247 |
| BBB | 0.208 |
| PPB | 0.979406 |
| VDSS | 1.635 |
| FU | 0.0257357 |
| CYP1A2-inh | 0.954 |
| CYP1A2-sub | 0.21 |
| CYP2c19-inh | 0.858 |
| CYP2c19-sub | 0.071 |
| CYP2c9-inh | 0.487 |
| CYP2c9-sub | 0.919 |
| CYP2d6-inh | 0.899 |
| CYP2d6-sub | 0.367 |
| CYP3a4-inh | 0.414 |
| CYP3a4-sub | 0.098 |
| CL | 11.876 |
| T12 | 0.873 |
| hERG | 0.068 |
| Ames | 0.089 |
| ROA | 0.019 |
| SkinSen | 0.94 |
| Carcinogencity | 0.117 |
| EI | 0.976 |
| Respiratory | 0.216 |
| NR-Aromatase | 0.906 |
| Antiviral | Yes |
| Prediction | 0.79482 |